NanoString Blog
Author: NanoString
Miscellaneous
AMP-ed Up for Clinical Evaluation with GeoMx DSP
The Association for Molecular Pathology (AMP) joined the list of conferences to go virtual in 2020. NanoString was online with workshops highlighting uses for the groundbreaking GeoMx® Digital Spatial Profiler…
Infectious Disease
COVID-19: The Fall Edition
Normally, the months of September and October are dotted with important dates—end of summer barbeques, the first day of school, joyful plans for Halloween and excitement for the upcoming Holiday…
Autoimmunity
Q&A with Dr. Maureen McGargill, PhD: The Immune System’s Fine Line Between Health and Harm
Dr. McGargill earned her PhD at the University of Minnesota in Dr. Kristin Hogquist’s lab. There she studied T cell development, focusing on how autoreactive T cells are deleted during…
Oncology
Q&A with Dr. Lisa Butterfield, PhD: Cancer Vaccines & Adoptive Cell Transfer
Dr. Lisa Butterfield, PhD recently joined the Parker Institute for Cancer Immunotherapy as Vice President focusing on cell therapies while she continues her independent cancer vaccine research as an Adjunct…
Autoimmunity
Q&A with Dr. Salla Keskitalo: Challenges and Opportunities in Studying Rare and Ultra-rare Autoimmune Diseases
Dr. Salla Keskitalo is a Senior Research Scientist at the University of Helsinki and a recent winner of NanoString’s Autoimmunity Grant Program. She made time to speak with us about…
Oncology
Q&A with Drs. Torsten Nielsen and Tony Ng and Angela Goytain: Development of a Sarcoma Gene Fusion Assay Faster Than FISH and Simpler than NGS
The NanoString nCounter is Research Use Only and not for diagnostic use. The views expressed herein are solely those of the interviewed researchers. Torsten Nielsen, MD, PhD is a pathologist…
Neuroscience
Q&A with Dr. Gregory Carter: Developing Computational Strategies and the MODEL-AD Consortium
Gregory Carter, Ph.D., is an Associate Professor at The Jackson Laboratory. His work is focused on developing computational strategies using genetic data to understand complex genetic systems. We recently spoke…
Oncology
Q&A with Dr. Juliane Nguyen: Exosome Profiling with miRNA and Biotech’s Next Breakthrough
Dr. Juliane Nguyen is a professor in the Department of Pharmaceutical Sciences at the University of Buffalo. Her Therapeutic Biomaterials Laboratory investigates using exosomes and other nanoscale carriers for the…
Autoimmunity
Q&A with Darragh Duffy, Ph.D. – Understanding the Healthy Human Immune Response with the LabEx Milieu Interieur Project
Darragh Duffy, Ph.D., is the Scientific Manager of the LabEx Milieu Interieur project at the Institut Pasteur in Paris, France. This ambitious program started in 2011 with the mission to understand…
Digital Spatial Profiling Neuroscience
Q&A with Dr. Stefan Prokop – Alzheimer’s: From the Amyloid Hypothesis to the Cellular Phase and Beyond
Stefan Prokop, MD, is a Neuropathologist and Research Fellow at the University of Pennsylvania School of Medicine. His work is focused on Alzheimer’s Disease (AD) with a specific interest in…
nCounter
nCounter® PlexSet™ Reagents Let You Work Smarter, Not Harder
There are several options available to researchers looking to quantify and analyze gene expression. Most of those are time-consuming and highly technical processes that require extensive replicates and quality controls.…
Neuroscience
Researcher Profiles: How NanoString® Neuroscience Grant Program Winners are Utilizing nCounter® Technology
Earlier this year, five neuro grant program applicants were awarded nCounter® Neuropathology or Neuroinflammation Panels to profile 24 samples. Applications spanned a wide range of disease specific applications with the…